Skip to main content
Erschienen in: Virology Journal 1/2020

Open Access 01.12.2020 | COVID-19 | Short report

Characterization of codon usage pattern in SARS-CoV-2

verfasst von: Wei Hou

Erschienen in: Virology Journal | Ausgabe 1/2020

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed significant threats to international health. The genetic traits as well as evolutionary processes in this novel coronavirus are not fully characterized, and their roles in viral pathogenesis are yet largely unknown. To get a better picture of the codon architecture of this newly emerging coronavirus, in this study we perform bioinformatic analysis, based on publicly available nucleotide sequences of SARS-CoV-2 along with those of other members of human coronaviruses as well as non-human coronaviruses in different hosts, to take a snapshot of the genome-wide codon usage pattern of SARS-CoV-2 and uncover that all over-represented codons end with A/U and this newly emerging coronavirus has a relatively low codon usage bias, which is shaped by both mutation pressure and natural selection. Additionally, there is slight variation in the codon usage pattern among the SARS-CoV-2 isolates from different geo-locations. Furthermore, the overall codon usage pattern of SARS-CoV-2 is generally similar to that of its phylogenetic relatives among non-human betacoronaviruses such as RaTG13. Taken together, we comprehensively analyze the characteristics of codon usage pattern in SARS-CoV-2 via bioinformatic approaches. The information from this research may not only be helpful to get new insights into the evolution of SARS-CoV-2, but also have potential value for developing coronavirus vaccines.
Begleitmaterial
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12985-020-01395-x.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
COVID-19
Coronavirus disease 2019
CoVs
Coronaviruses
SARS-CoV
Severe acute respiratory syndrome coronavirus
MERS-CoV
Middle East respiratory syndrome coronavirus
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
RSCU
Relative synonymous codon usage
ICDI
Intrinsic codon bias index
CBI
Codon bias index
ENC
Effective number of codons

Introduction

Coronaviruses (CoVs) belong to the family Coronavirdiae comprises large, single, positive-sense single-stranded RNA viruses including four genera of CoVs, namely, Alphacoronavirus, Betacoronavirus, Deltacoronavirus, and Gammacoronavirus [1]. Several coronavirus species were extensively known to cause human disease [13], including two alphacoronaviruses (HCoV-229E, HCoV-NL63) and four betacoronaviruses (HCoV-OC43, HCoV-HKU, sereve acute respiratory syndrome coronavirus SARS-CoV and Middle East respiratory syndrome coronavirus MERS-CoV). Very recently, the outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed significant threats to international health [49]. However, the genetic traits as well as evolutionary processes in this newly emerging coronavirus are not fully characterized, and their roles in viral pathogenesis are yet largely unknown. To further explore the codon usage pattern of SARS-CoV-2 to get a better picture of the codon architecture of this novel coronavirus, genomic sequences of the SARS-CoV-2 and other representative coronaviruses were analyzed via bioinformatic approaches.

Materials and methods

Genomic sequences acquisition

Genomic sequences of the SARS-CoV-2 Wuhan-Hu-1 (MN908947.3), other representative coronaviruses including human coronaviruses such as HCoV-229E (AF304460.1), HCoV-NL63 (AY567487.2), HCoV-OC43(AY585228.1), HCoV-HKU1(MH940245.1), and SARS-CoV (strain: Urbani, AY278741.1; strain: Tor2, AY274119.3), MERS-CoV (strain: HCoV-EMC, JX869059.2) and nonhuman coronaviruses (Supplementary Table 1) were all retrieved from GenBank.

Phylogenetic analysis

Phylogenetic tree of the whole genome sequences of coronaviruses were constructed by using MEGA software version 6.0 (http://​www.​megasoftware.​net) with the maximum likelihood algorithm and Kimura 2-parameter model with 1000 bootstrap replicates.

Codon usage pattern analysis

The basic nucleotide composition (A%, U%, C%, and G%), AU and GC contents, relative synonymous codon usage (RSCU) were analyzed using MEGA software. The parameters of codon usage bias including intrinsic codon bias index (ICDI), codon bias index (CBI), effective number of codons (ENC) were analyzed using CAIcal [10] and COUSIN programs (http://​cousin.​ird.​fr/​index.​php).

Cluster analysis

Cluster analysis (Heat map) was performed using CIMminer (https://​discover.​nci.​nih.​gov/​cimminer/​).

Results and discussion

Phylogenetic analysis of human coronavirus genomes (Fig. 1a) revealed that the newly identified coronavirus SARS-CoV-2 Wuhan-Hu-1 sequence was closer to SARS-CoV Tor2 as well as SARS-CoV Urbani, and relatively distant to two alphacoronaviruses (HCoV-229E, HCoV-NL63).
Nucleotide composition analysis (Supplementary Figure 1A) revealed that SARS-CoV-2 Wuhan-Hu-1 had the highest compositional value of U% (32.2) which was followed by A% (29.9), and similar composition of G% (19.6) and C% (18.3). At the third position, we observed that nucleotide U also occurred most frequently. Thus, most codons of SARS-CoV-2 Wuhan-Hu-1 tended to be U ending. Moreover, the mean GC and AU compositions (Supplementary Figure 1B) were 37.9 and 62.1% (SARS-CoV-2 Wuhan-Hu-1), 41.0 and 59.0% (SARS-CoV Tor2), 40.8 and 59.2% (SARS-CoV Urbani), 41.5 and 58.5% (MERS-CoV HCoV-EMC), 36.8 and 63.2% (HCoV-OC43), 32.0 and 68.0% (HCoV-HKU1), 38.0 and 62.0% (HCoV-229E), 34.4 and 65.6% (HCoV-NL63), respectively indicating that SARS-CoV-2 Wuhan-Hu-1 as well as other human coronaviruses in this study were all AU rich, which was consistent with recent reports [1115].
RSCU analysis of the complete coding sequences of SARS-CoV-2 Wuhan-Hu-1 revealed that all the over-represented codons (RSCU value > 1.6) ended with A/U whereas most of the under-represented codons (RSCU value < 0.6) ended with C/G (Supplementary Table 2). The highest RSCU value for the codon was AGA for R (2.67) amino acid and the lowest was UCG for S (0.11). The heatmap analysis (Fig. 1b) further revealed that all human coronaviruses analyzed in this study share the over-represented codons (UAA, GGU, GCU, UCU, GUU, CCU, ACU) and the average RSCU value > 2.0, whereas UCA were over-represented only in SARS-CoV-2 and SARS-CoV.
The profiles of codon usage patterns among different genes of human coronaviruses were further analyzed (Figs. 1c and 2). As for spike (S) gene, all human coronaviruses analyzed in this study shared the over-represented codons (UCU, GCU, CUU, GUU, ACU) and all ended with U, whereas two codons (CCA, ACA) were over-represented only in SARS-CoV-2. In addition, SARS-CoV-2 did not use CGA for arginine nor CCG for proline. As for envelop (E) gene, two codons (UAC, GCG) were over-represented only in SARS-CoV-2 and SARS-CoV. All human coronaviruses analyzed in this study did not use two synonymous codons (CGC, CGG) for arginine as well as CCG for proline and UGA for stop codon at all. SARS-CoV-2 and SARS-CoV did not use CAA for glutamine nor UAU for tyrosine, whereas they use GCG for alanine, AUC for isoleucine, UCG and AGC for serine. As for membrane (M) gene, three codons (GUA, GAA, GGA) were over-represented only in SARS-CoV-2. As for nucleocapsid (N) gene, all human coronaviruses analyzed in this study share the over-represented codons (GCU, ACU, CUU) and all ended with U. The average RSCU values of GCU in complete gene, S gene, E gene, M gene and N gene in all human coronaviruses analyzed in this study were 2.22, 2.12, 1.79, 2.13, 2.16, respectively. GCU for alanine was identified as the highly preferred codon among the human coronaviruses.
Amino acids are degenerate and each amino acid has different number of synonymous codons except for methionine (Met, M) and tryptophan (Trp, W). The overall amino acid usage of the human coronaviruses was shown in Supplementary Figure 2. Leucine and valine were the two most frequently used amino acids in all human coronaviruses analyzed in this study, CUU and GUU were preferred codons for leucine and valine, respectively (Fig. 3), whereas tryptophan, histidine and methionine were the three least used ones, which was consistent with recent report [14].
To further estimate the degree of codon usage bias, intrinsic codon bias index (ICDI), codon bias index (CBI) and effective number of codons (ENC) values were calculated (Table 1). ICDI value (0.144), CBI value (0.306) and ENC value (45.38) all exhibited relatively low codon usage bias of SARS-CoV-2, similar to SARS-CoV Tor2, SARS-CoV Urbani, MERS-CoV HCoV-EMC, HCoV-OC43, HCoV-229E whereas different from HCoV-HKU1 (ICDI 0.372; CBI 0.532; ENC 35.617) and HCoV-NL63 (ICDI 0.307; CBI 0.476; ENC 37.275), which exhibited moderate codon usage bias.
Table 1
The parameters of codon usage bias among the coronaviruses analyzed in this study
Coronaviruses
GenBank Accession
Genome Length (nt)
ICDI
CBI
ENC
SARS-CoV-2 Wuhan-Hu-1
MN908947.3
29,903
0.144
0.306
45.38
SARS-CoV Tor2
AY274119.3
29,751
0.075
0.223
49.746
SARS-CoV Urbani
AY278741.1
29,727
0.08
0.228
48.965
MERS-CoV HCoV-EMC
JX869059.2
30,119
0.082
0.248
50.033
HCoV-OC43
AY585228.1
30,741
0.213
0.367
43.794
HCoV-HKU1
MH940245.1
29,811
0.372
0.532
35.617
HCoV-229E
AF304460.1
27,317
0.172
0.358
43.45
HCoV-NL63
AY567487.2
27,553
0.307
0.476
37.275
We next attempted to determine the forces influencing the codon usage bias. Accumulating evidence suggests that the formation of codon usage bias is affected by many factors, and two generally accepted major forces are mutation pressure and natural selection [16]. Other influential factors include gene expression level, gene length, GC content, GC contents at the third base of one codon (GC3), RNA stability, hydrophilicity, and hydrophobicity, etc. When G or C is in high or low proportion at the third position of the codon, mutational pressure is involved [17]. From Supplementary Figure 1, it clearly showed that both G3 and C3 were lower than A3 and U3, suggesting the contribution of mutational force acting on codon usage pattern. Moreover, all preferred codons were A/U ending (Figs. 1b, c and 2), which further suggested that mutational force contributed to shape codon usage in this virus. Furthermore, to better understand the relation between gene composition and codon usage bias, an ENC–GC3 scatter diagram of ENC versus GC3S (ENC plotted against G + C content at the third codon position) was constructed. When codon usage pattern is only affected by GC3 resulting from mutation pressure, the expected ENC values should be just on the solid curved line. As shown in Supplementary Figure 3, all points lie together under the expected ENC curve, indicating that some independent factors, such as natural selection might also play a role in codon usage bias of human coronaviruses.
Apart from human, many animal species can also be infected by different types of coronaviruses. Previous studies have shown that some animals such as bats are believed to represent the original reservoir of several human-infecting coronaviruses [1]. In order to provide additional information to better understand the evolution of SARS-CoV-2, we further compared the codon usage pattern of SARS-CoV-2 and non-human coronaviruses (Supplementary Table 1).
Phylogenetic analysis (Fig. 4a) showed that SARS-CoV-2 was most closely related to recently reported Bat coronavirus RaTG13 [8]. Nucleotide composition analysis (Supplementary Figure 4) revealed that similar to SARS-CoV-2 Wuhan-Hu-1, all the non-human coronaviruses analyzed in this study had the highest compositional value of U% and nucleotide U occurred most frequently at the third position. The heatmap analysis (Fig. 4b) revealed that SARS-CoV-2 and all the non-human coronaviruses analyzed in this study shared the over-represented codons (GGU, UCU, CCU) and all ended with U, meanwhile they shared the under-represented codons (UCG, GGG, GCG, CCG, CGG, ACG, CGA) and most ended with G except for CGA. Codon usage pattern of SARS-CoV-2 was generally found a high similarity to that of betacoronaviruses except for Bat coronavirus HKU4–1, Bat coronavirus HKU5–1(Fig. 4c, Supplementary Figures 5, 6, 7, 8). Moreover, the profiles of codon usage patterns among different genes of SARS-CoV-2 and non-human coronaviruses were further analyzed, as shown in Fig. 5 and Supplementary Figures 9, 10, 11, 12. We found similar codon usage pattern among SARS-CoV-2 and its phylogenetic relatives such as RaTG13, Bat-SL-CoVZC45, Bat-SL-CoVZXC21, PCoV_GX-P1E, PCoV_GX-P4L, which may reflect the evolutionary relationship between SARS-CoV-2 and these non-human coronaviruses. These results are in accordance with the full-genome phylogenetic analysis (Fig. 4a). The overall amino acid usage of the non-human coronaviruses was shown in Supplementary Figure 13. Similar to SARS-CoV-2, leucine and valine were the two most frequently used amino acids in all non-human coronaviruses analyzed in this study, CUU and GUU were preferred codons for leucine and valine, respectively.
Furthermore, similar to SARS-CoV-2, all the non-human coronaviruses analyzed in this study exhibited relatively low codon usage bias according to the intrinsic codon bias index (ICDI), codon bias index (CBI) and effective number of codons (ENC) values, as shown in Supplementary Figure 14. Nucleotide composition analysis (Supplementary Figure 4) and ENC-GC3S plot (Supplementary Figure 15) revealed that both mutational force and natural selection contribute to shape codon usage in non-human coronaviruses.
Overall, in the present study we attempted to take a snapshot of the characteristics of codon usage pattern in novel coronavirus SARS-CoV-2. As a result, we found all over-represented codons ended with A/U and this novel coronavirus had a relatively low codon usage bias. Both mutation pressure and natural selection were contributors to the bias. Additionally, the overall codon usage pattern of SARS-CoV-2 was generally similar to that of its phylogenetic relatives among non-human coronaviruses such as RaTG13. Our findings are consistent with the recent observations [1115] and provide new insights into the characteristics of codon usage pattern in coronaviruses. These results also have important implications for future work.
Firstly, the information of genome-wide codon usage pattern of SARS-CoV-2 may be helpful to get new insights into the evolution of this newly emerging virus. With the increase of SARS-CoV-2 genome data available, we could reevaluate the codon usage pattern of SARS-CoV-2 more comprehensively to track the evolutionary changes between them. In this regard, genome-wide codon usage patterns in 100 complete genome sequences of SARS-CoV-2 isolates including SARS-CoV-2 Wuhan-Hu-1 from different geo-locations were analyzed herein. All information about the isolates can be found in Supplementary Table 3. The heatmap analysis (Supplementary Figure 16) revealed 12 preferred codons (GGU, GCU, UAA, GUU, UCU, CCU, ACU UAA, GGU, GCU, UCU, GUU, CCU, ACU) ending with A/U among all the 100 isolates, and the average RSCU value of these over-represented codons vary from 1.63 to 2.67 (Supplementary Figure 17). The highest RSCU value was for the codon AGA for R (2.67) amino acid and the lowest was UCG for S (0.11). We noted that the overall codon usage pattern appeared to be slightly variant among the tested 100 SARS-CoV-2 isolates from different geo-locations, reflecting minimal evolutionary changes among them.
Additionally, compared to other members of human coronaviruses as well as non-human coronaviruses in different hosts, we found that the overall codon usage pattern of SARS-CoV-2 is generally similar to that of its phylogenetic relatives among non-human betacoronaviruses such as RaTG13 (Fig. 5), which may reflect the evolutionary relationship between SARS-CoV-2 and these non-human coronaviruses.
Secondly, the information of genome-wide codon usage pattern of SARS-CoV-2 may have potential value for developing coronavirus vaccines to combat this pandemic disease. The information on codon usage by SARS-CoV-2 may pave the way to design strategies such as codon deoptimization [1820], the use of the least preferred codons to modify the SARS-CoV-2 genome to reduce virulence for the development of a safe and effective vaccine. This strategy has several advantages. Deoptimized viruses could express an identical antigenic repertoire of T- and B-cell epitopes because they contain the intact wide type amino acid sequence. Moreover, deoptimized viruses can efficiently replicate in vitro while being highly attenuated in vivo, which is important for vaccine production and their safe implementation.

Conclusions

Taking all these results together, our studies reveal that SARS-CoV-2 has a relatively low codon usage bias, which is shaped by both mutation pressure and natural selection. Additionally, there is slight variation in the codon usage pattern among the SARS-CoV-2 isolates from different geo-locations. Furthermore, the overall codon usage pattern of SARS-CoV-2 is generally similar to that of its phylogenetic relatives among non-human betacoronaviruses such as RaTG13. The information from this research may not only be helpful to get new insights into the evolution of human coronaviruses, but also have potential value for developing coronavirus vaccines.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12985-020-01395-x.

Acknowledgements

We thank researchers for making viral sequences available for public access.
Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Supplementary information

Literatur
1.
Zurück zum Zitat Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–92.CrossRef Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–92.CrossRef
2.
Zurück zum Zitat de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–34.CrossRef de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–34.CrossRef
3.
Zurück zum Zitat Graham RL, Donaldson EF, Baric RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol. 2013;11:836–48. Graham RL, Donaldson EF, Baric RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol. 2013;11:836–48.
4.
Zurück zum Zitat Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.
5.
Zurück zum Zitat Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
6.
Zurück zum Zitat Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–23. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–23.
7.
Zurück zum Zitat Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–9. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–9.
8.
Zurück zum Zitat Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.
9.
Zurück zum Zitat Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol. 2020;92:433–40.CrossRef Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol. 2020;92:433–40.CrossRef
10.
Zurück zum Zitat Puigbò P, Bravo IG, Garcia-Vallve S. CAIcal: a combined set of tools to assess codon usage adaptation. Biol Direct. 2008;3:38.CrossRef Puigbò P, Bravo IG, Garcia-Vallve S. CAIcal: a combined set of tools to assess codon usage adaptation. Biol Direct. 2008;3:38.CrossRef
11.
Zurück zum Zitat Khodary SM, Anwar AM. Insights into the codon usage bias of 13 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates from different geo-locations. bioRxiv. 2020.04.01.019463. Khodary SM, Anwar AM. Insights into the codon usage bias of 13 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates from different geo-locations. bioRxiv. 2020.04.01.019463.
12.
Zurück zum Zitat Dilucca M, Forcelloni S, Georgakilas AG, Giansanti A, Pavlopoulou A. Codon usage and phenotypic divergences of SARS-CoV-2 genes. Viruses. 2020;12:498. Dilucca M, Forcelloni S, Georgakilas AG, Giansanti A, Pavlopoulou A. Codon usage and phenotypic divergences of SARS-CoV-2 genes. Viruses. 2020;12:498.
13.
Zurück zum Zitat Kandeel M, Ibrahim A, Fayez M, Al-Nazawi M. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes. J Med Virol. 2020;92:660–6. Kandeel M, Ibrahim A, Fayez M, Al-Nazawi M. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes. J Med Virol. 2020;92:660–6.
14.
Zurück zum Zitat Gu H, Chu DKW, Peiris M, Poon LLM. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses. Virus Evol. 2020;6:veaa032. Gu H, Chu DKW, Peiris M, Poon LLM. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses. Virus Evol. 2020;6:veaa032.
15.
Zurück zum Zitat Tort FL, Castells M, Cristina J. A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses. Virus Res. 2020;283:197976. Tort FL, Castells M, Cristina J. A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses. Virus Res. 2020;283:197976.
16.
Zurück zum Zitat Plotkin JB, Kudla G. Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet. 2011;12:32–42. Plotkin JB, Kudla G. Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet. 2011;12:32–42.
17.
Zurück zum Zitat Chaney JL, Clark PL. Roles for synonymous codon usage in protein biogenesis. Annu Rev Biophys. 2015;44:143–66. Chaney JL, Clark PL. Roles for synonymous codon usage in protein biogenesis. Annu Rev Biophys. 2015;44:143–66.
18.
Zurück zum Zitat Baker SF, Nogales A, Martínez-Sobrido L. Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines. Future Virol. 2015;10:715–30. Baker SF, Nogales A, Martínez-Sobrido L. Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines. Future Virol. 2015;10:715–30.
19.
Zurück zum Zitat Fan RL, Valkenburg SA, Wong CK, Li OT, Nicholls JM, Rabadan R, Peiris JS, Poon LL. Generation of live attenuated influenza virus by using codon usage bias. J Virol. 2015;89:10762–73. Fan RL, Valkenburg SA, Wong CK, Li OT, Nicholls JM, Rabadan R, Peiris JS, Poon LL. Generation of live attenuated influenza virus by using codon usage bias. J Virol. 2015;89:10762–73.
20.
Zurück zum Zitat Blanco-Lobo P, Nogales A, Rodríguez L, Martínez-Sobrido L. Novel approaches for the development of live attenuated influenza vaccines. Viruses. 2019;11:190. Blanco-Lobo P, Nogales A, Rodríguez L, Martínez-Sobrido L. Novel approaches for the development of live attenuated influenza vaccines. Viruses. 2019;11:190.
Metadaten
Titel
Characterization of codon usage pattern in SARS-CoV-2
verfasst von
Wei Hou
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Virology Journal / Ausgabe 1/2020
Elektronische ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-020-01395-x

Weitere Artikel der Ausgabe 1/2020

Virology Journal 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.